Neurocrine Bio. (NBIX) PT Lowered to $123 at RBC Capital
Tweet
Share
E-mailGet Alerts NBIX Hot Sheet
Price: $154.49 +1.16%
Rating Summary:
30 Buy, 6 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Rating Summary:
30 Buy, 6 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
RBC Capital analyst Brian Abrahams lowered the price target on Neurocrine Bio. (NASDAQ: NBIX) to $123.00 (from $136.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Freedom Broker Upgrades PrimeEnergy Resource (PNRG) to Hold
- York Space Systems (YSS) PT Lowered to $15 at Jefferies
- Ashok Leyland Ltd. (AL:IN) PT Raised to INR194 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
